ADRB3 and melanoma: Studies on murine B16-F10 melanoma cells demonstrated for the first time that the pharmacological β3-AR blockade was able to reduce proliferation and induce apoptosis of melanoma cells in vitro; these effects were also reproduced by using a siRNA molecular approach targeting specific β-ARs [86].